FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Second suspect arrested after NYC snowball fight sends 2 police officers to hospital

DOJ quietly closes autopen investigation targeting Biden and aides

Top Trump ally Steve Daines exits Montana Senate race, plans to retire

GOP senators tangle with Noem during heated hearing on her handling of deportation surge

Unearthed video shows Dem candidate supporting ‘reallocation’ of police funding to social service programs

Popular Far-Left Streamer Advises Suicide Bombers to Switch to Drones for Terror Campaigns

Perfect Justice: We’re Raining Destruction on Iran Using a Suicide Drone They Designed But We Perfected

BREAKING: Senate Rejects Dems’ War Powers Resolution Trying to Tie Trump’s Hands on Iran

DHS defends McLaughlin against allegations husband’s company profited millions from ad contracts: ‘Baseless’

Rep. Tony Gonzales admits to affair with staffer who died by suicide: ‘Lapse in judgment’

Minnesota AG Keith Ellison Feels the Heat During Fraud Hearing in DC: ‘You Should Go to Jail’

FBI spox unleashes on media’s ‘transparent spin job’ that recent firings were ‘devastating’ to Iran work

Pam Bondi faces bipartisan subpoena over frustration with DOJ’s release of Epstein files

Pritzker Tries to Laugh Off Bill Clinton’s Under Oath Statement That Illinois Governor Traveled with Epstein

Developing: FBI Investigating as Mystery ‘Holocaust 2.0’ Messages Make Their Way to Stanford Students

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”